Home

Cam Gallagher

CIK 1557832 · President, Interim CFO · last filed 2026-04-22

Cam Gallagher is a President, Interim CFO who has filed 69 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for OCUP, was dated Apr 22, 2026. Across all open-market trades the lifetime net is −$21.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.94M

Companies

3

Total Filings

69

Lifetime Open-Market Net

-$21.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Opus Genetics, Inc. (OCUP) Delisted Director 2,098,797 $1.17 $2.46M $323.7K 14 2026-04-22
ZNTL President, Interim CFO 636,753 $4.62 $2.94M -$22.25M 45 2024-05-31
Sorrento Therapeutics, Inc. (SRNE) Delisted Director — $0.00 — $0 2 2014-01-24

Recent Filings

69 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-22 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +24,367 $0 EDGAR
2026-01-08 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +67,000 $0 EDGAR
2025-12-31 Opus Genetics, Inc. (OCUP) Delisted Mixed +197,000 $323.7K EDGAR
2025-08-27 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +869,565 $1000.0K EDGAR
2025-05-02 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +79,504 $0 EDGAR
2025-03-26 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +784,314 $0 EDGAR
2025-02-11 ZNTL Notice (144) −687 -$1.4K EDGAR
2025-02-03 ZNTL Notice (144) −28,558 -$48.9K EDGAR
2024-06-13 Opus Genetics, Inc. (OCUP) Delisted Grant (A) +41,143 $0 EDGAR
2024-05-31 ZNTL Notice (144) −9,597 -$115.0K EDGAR
Showing 1–10 of 69
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.